Publications by authors named "M R P L Pitman"

Background: Major mutations (e.g., KRAS, GNAS, TP53, SMAD4) in pancreatic cyst fluid (PCF) are useful for classifying and risk stratifying certain cyst types, particularly in cases with nondiagnostic cytology.

View Article and Find Full Text PDF
Article Synopsis
  • * The standard treatment—surgery and chemotherapy—causes significant side effects and reduces patients' quality of life, highlighting the need for new, less toxic therapies.
  • * Research on plasma-activated media (PAM) shows it may be more effective than traditional chemotherapy, promoting cancer cell death and oxidative stress in HGSOC, paving the way for future clinical applications.
View Article and Find Full Text PDF

Objective: To determine postgraduate job selection, percentage of career movement, factors influencing these decisions, and job satisfaction of laryngologists within academic and nonacademic fields.

Study Design: Cross-sectional survey.

Setting: Nonacademic and academic laryngology practices across the United States.

View Article and Find Full Text PDF

Objectives: Retrograde Cricopharyngeal Dysfunction (RCPD) is treated by botulinum toxin (BTX) injection into the cricopharyngeus. This prospective study compares the effectiveness and side effects of operating room (OR) and in-office (IO) injections.

Methods: Patients over 18 years of age with inability to burp, abdominal, thoracic, or cervical gurgling sounds, bloating, and excessive flatulence were diagnosed with RCPD and included in the study.

View Article and Find Full Text PDF

Kaposi sarcoma (KS) is a low-grade vascular neoplasm that can be seen in various sites, most commonly seen in skin and mucosal tissues. Cytologic features of KS have been well-documented in the literature, however, since it is rarely seen in visceral organs, it could pose significant diagnostic challenges on fine needle aspiration (FNA) biopsies. We present a case of pulmonary KS diagnosed on transbronchial FNA biopsy in a 70-year-old female bilateral lung allograft recipient 11 months after transplantation.

View Article and Find Full Text PDF